Global Nucleic Acid Amplification Testing Market Report and Forecast 2024-2032

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions
    1.3    Report Coverage – Key Segmentation and Scope 
    1.4    Research Methodology
2    Executive Summary
3    Global Nucleic Acid Amplification Testing Market Overview 
    3.1    Global Nucleic Acid Amplification Testing Market Historical Value (2017-2023) 
    3.2    Global Nucleic Acid Amplification Testing Market Forecast Value (2024-2032)
4    Vendor Positioning Analysis 
    4.1    Key Vendors
    4.2    Prospective Leaders
    4.3    Niche Leaders
    4.4    Disruptors
5    Global Nucleic Acid Amplification Testing Market Landscape*
    5.1    Global Urinalysis: Developers Landscape
        5.1.1    Analysis by Year of Establishment
        5.1.2    Analysis by Company Size
        5.1.3    Analysis by Region
    5.2    Global Urinalysis: Product Landscape 
        5.2.1    Analysis by Technique
6    Global Nucleic Acid Amplification Testing Market Dynamics
    6.1    Market Drivers and Constraints
    6.2    SWOT Analysis
        6.2.1    Strengths
        6.2.2    Weaknesses
        6.2.3    Opportunities
        6.2.4    Threats
    6.3    PESTEL Analysis
        6.3.1    Political
        6.3.2    Environmental
        6.3.3    Social
        6.3.4    Technological
        6.3.5    Ethical
        6.3.6    Legal
    6.4    Porter’s Five Forces Model
        6.4.1    Bargaining Power of Suppliers
        6.4.2    Bargaining Power of Buyers
        6.4.3    Threat of New Entrants
        6.4.4    Threat of Substitutes
        6.4.5    Degree of Rivalry
    6.5    Key Demand Indicators 
    6.6    Key Price Indicators
    6.7    Industry Events, Initiatives, and Trends  
    6.8    Value Chain Analysis
7    Global Nucleic Acid Amplification Testing Market Segmentation (2017-2032)
    7.1    Global Nucleic Acid Amplification Testing Market (2017-2032) by Technique
        7.1.1    Market Overview
        7.1.2    Polymerase Chain Reaction (PCR)
        7.1.3    Transcription-Mediated Amplification (TMA)
        7.1.4    Loop-Mediated Isothermal Amplification (LAMP)
        7.1.5    Nucleic Acid Sequence-Based Amplification (NASBA)
        7.1.6    Others
    7.2    Global Nucleic Acid Amplification Testing Market (2017-2032) by Application
        7.2.1    Market Overview
        7.2.2    Infectious Disease Diagnosis
        7.2.3    Cancer Diseases
        7.2.4    Genetic Testing
        7.2.5    Blood Screening
        7.2.6    Others
    7.3    Global Nucleic Acid Amplification Testing Market (2017-2032) by End User
        7.3.1    Market Overview
        7.3.2    Hospitals
        7.3.3    Diagnostic Laboratories
        7.3.4    Research Institutes
        7.3.5    Pharmaceutical and Biotechnology Companies
    7.4    Global Nucleic Acid Amplification Testing Market (2017-2032) by Region
        7.4.1    Market Overview
        7.4.2    North America
        7.4.3    Europe 
        7.4.4    Asia Pacific
        7.4.5    Latin America
        7.4.6    Middle East and Africa
8    North America Nucleic Acid Amplification Testing Market (2017-2032)
    8.1    North America Nucleic Acid Amplification Testing Market (2017-2032) by Technique
        8.1.1    Market Overview
        8.1.2    Polymerase Chain Reaction (PCR)
        8.1.3    Transcription-Mediated Amplification (TMA)
        8.1.4    Loop-Mediated Isothermal Amplification (LAMP)
        8.1.5    Nucleic Acid Sequence-Based Amplification (NASBA)
        8.1.6    Others
    8.2    North America Nucleic Acid Amplification Testing Market (2017-2032) by Application
        8.2.1    Market Overview
        8.2.2    Infectious Disease Diagnosis
        8.2.3    Cancer Diseases
        8.2.4    Genetic Testing
        8.2.5    Blood Screening
        8.2.6    Others
    8.3    North America Nucleic Acid Amplification Testing Market (2017-2032) by End User
        8.3.1    Market Overview
        8.3.2    Hospitals
        8.3.3    Diagnostic Laboratories
        8.3.4    Research Institutes
        8.3.5    Pharmaceutical and Biotechnology Companies
    8.4    North America Nucleic Acid Amplification Testing Market (2017-2032) by Country
        8.4.1    United States of America
        8.4.2    Canada
9    Europe Nucleic Acid Amplification Testing Market (2017-2032)
    9.1    Europe Nucleic Acid Amplification Testing Market (2017-2032) by Technique
        9.1.1    Market Overview
        9.1.2    Polymerase Chain Reaction (PCR)
        9.1.3    Transcription-Mediated Amplification (TMA)
        9.1.4    Loop-Mediated Isothermal Amplification (LAMP)
        9.1.5    Nucleic Acid Sequence-Based Amplification (NASBA)
        9.1.6    Others
    9.2    Europe Nucleic Acid Amplification Testing Market (2017-2032) by Application
        9.2.1    Market Overview
        9.2.2    Infectious Disease Diagnosis
        9.2.3    Cancer Diseases
        9.2.4    Genetic Testing
        9.2.5    Blood Screening
        9.2.6    Others
    9.3    Europe Nucleic Acid Amplification Testing Market (2017-2032) by End User
        9.3.1    Market Overview
        9.3.2    Hospitals
        9.3.3    Diagnostic Laboratories
        9.3.4    Research Institutes
        9.3.5    Pharmaceutical and Biotechnology Companies
    9.4    Europe Nucleic Acid Amplification Testing Market (2017-2032) by Country
        9.4.1    United Kingdom
        9.4.2    Germany
        9.4.3    France
        9.4.4    Italy
        9.4.5    Others
10    Asia Pacific Nucleic  Acid Amplification Testing Market (2017-2032)
    10.1    Asia Pacific Nucleic Acid Amplification Testing Market (2017-2032) by Technique
        10.1.1    Market Overview
        10.1.2    Polymerase Chain Reaction (PCR)
        10.1.3    Transcription-Mediated Amplification (TMA)
        10.1.4    Loop-Mediated Isothermal Amplification (LAMP)
        10.1.5    Nucleic Acid Sequence-Based Amplification (NASBA)
        10.1.6    Others
    10.2    Asia Pacific Nucleic Acid Amplification Testing Market (2017-2032) by Application
        10.2.1    Market Overview
        10.2.2    Infectious Disease Diagnosis
        10.2.3    Cancer Diseases
        10.2.4    Genetic Testing
        10.2.5    Blood Screening
        10.2.6    Others
    10.3    Asia Pacific Nucleic Acid Amplification Testing Market (2017-2032) by End User
        10.3.1    Market Overview
        10.3.2    Hospitals
        10.3.3    Diagnostic Laboratories
        10.3.4    Research Institutes
        10.3.5    Pharmaceutical and Biotechnology Companies
    10.4    Asia Pacific Nucleic Acid Amplification Testing Market (2017-2032) by Country
        10.4.1    China
        10.4.2    Japan
        10.4.3    India
        10.4.4    ASEAN
        10.4.5    Australia
        10.4.6    Others
11    Latin America Nucleic Acid Amplification Testing Market (2017-2032
    11.1    Latin America Nucleic Acid Amplification Testing Market (2017-2032) by Technique
        11.1.1    Market Overview
        11.1.2    Polymerase Chain Reaction (PCR)
        11.1.3    Transcription-Mediated Amplification (TMA)
        11.1.4    Loop-Mediated Isothermal Amplification (LAMP)
        11.1.5    Nucleic Acid Sequence-Based Amplification (NASBA)
        11.1.6    Others
    11.2    Latin America Nucleic Acid Amplification Testing Market (2017-2032) by Application
        11.2.1    Market Overview
        11.2.2    Infectious Disease Diagnosis
        11.2.3    Cancer Diseases
        11.2.4    Genetic Testing
        11.2.5    Blood Screening
        11.2.6    Others
    11.3    Latin America Nucleic Acid Amplification Testing Market (2017-2032) by End User
        11.3.1    Market Overview
        11.3.2    Hospitals
        11.3.3    Diagnostic Laboratories
        11.3.4    Research Institutes
        11.3.5    Pharmaceutical and Biotechnology Companies
    11.4    Latin America Nucleic Acid Amplification Testing Market (2017-2032) by Country
        11.4.1    Brazil
        11.4.2    Argentina
        11.4.3    Mexico
        11.4.4    Others
12    Middle East and Africa Nucleic Acid Amplification Testing Market (2017-2032)
    12.1    Middle East and Africa Nucleic Acid Amplification Testing Market (2017-2032) by Technique
        12.1.1    Market Overview
        12.1.2    Polymerase Chain Reaction (PCR)
        12.1.3    Transcription-Mediated Amplification (TMA)
        12.1.4    Loop-Mediated Isothermal Amplification (LAMP)
        12.1.5    Nucleic Acid Sequence-Based Amplification (NASBA)
        12.1.6    Others
    12.2    Middle East and Africa Nucleic Acid Amplification Testing Market (2017-2032) by Application
        12.2.1    Market Overview
        12.2.2    Infectious Disease Diagnosis
        12.2.3    Cancer Diseases
        12.2.4    Genetic Testing
        12.2.5    Blood Screening
        12.2.6    Others
    12.3    Middle East and Africa Nucleic Acid Amplification Testing Market (2017-2032) by End User
        12.3.1    Market Overview
        12.3.2    Hospitals
        12.3.3    Diagnostic Laboratories
        12.3.4    Research Institutes
        12.3.5    Pharmaceutical and Biotechnology Companies
    12.4     Middle East and Africa Nucleic Acid Amplification Testing Market (2017-2032) by Country
        12.4.1    Saudi Arabia
        12.4.2    United Arab Emirates
        12.4.3    Nigeria
        12.4.4    South Africa
        12.4.5    Others
13    Regulatory Framework
    13.1    Regulatory Overview
    13.2    US FDA
    13.3    EU EMA
    13.4    INDIA CDSCO
    13.5    JAPAN PMDA
    13.6    Others
14    Strategic Initiatives
    14.1    Analysis by Partnership Instances
    14.2    Analysis by Type of Partnership and Collaborations
    14.3    Analysis by Joint Ventures 
    14.4    Analysis by Leading Players
    14.5    Analysis by Geography
15    Supplier  Landscape
    15.1    Market Share Analysis, By Region (Top 5 Companies) 
        15.1.1    Market Share Analysis: Global
        15.1.2    Market Share Analysis: North America
        15.1.3    Market Share Analysis: Europe
        15.1.4    Market Share Analysis: Asia-Pacific
        15.1.5    Market Share Analysis: Others
    15.2    Centre Testing International Group Co., Ltd .
        15.2.1    Financial Analysis
        15.2.2    Product Portfolio
        15.2.3    Demographic Reach and Achievements
        15.2.4    Mergers and Acquisitions
        15.2.5    Certifications 
    15.3    SYNGENE INTERNATIONAL LIMITED
        15.3.1  Financial Analysis
        15.3.2    Product Portfolio
        15.3.3    Demographic Reach and Achievements
        15.3.4    Mergers and Acquisitions
        15.3.5    Certifications
    15.4    NCIMB Ltd .
        15.4.1    Financial Analysis
        15.4.2    Product Portfolio
        15.4.3    Demographic Reach and Achievements
        15.4.4    Mergers and Acquisitions
        15.4.5    Certifications
    15.5    Apollo Global Management, Inc .
        15.5.1    Financial Analysis
        15.5.2    Product Portfolio
        15.5.3    Demographic Reach and Achievements
        15.5.4    Mergers and Acquisitions
        15.5.5    Certifications
    15.6    Vitality Urgent Care 
        15.6.1    Financial Analysis
        15.6.2    Product Portfolio
        15.6.3    Demographic Reach and Achievements
        15.6.4    Mergers and Acquisitions
        15.6.5    Certifications 
    15.7    Max Lab Limited 
        15.7.1    Financial Analysis
        15.7.2    Product Portfolio
        15.7.3    Demographic Reach and Achievements
        15.7.4    Mergers and Acquisitions
        15.7.5    Certifications
16    Global Nucleic  Acid Amplification Testing Market – Distribution Model (Additional Insight)
    16.1     Overview 
    16.2     Potential Distributors 
    16.3     Key Parameters for Distribution Partner Assessment 
17    Key Opinion Leaders (KOL) Insights (Additional Insight)

*Additional insights provided are customisable as per client requirements.

* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.

**The supplier list is not exhaustive. Moreover, we can provide analysis of companies as per custom requests.